Clinical Trials Directory

Trials / Completed

CompletedNCT04065880

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Postoperative prolonged air leak (PAL), referring to the passage of air from the lung parenchyma into the pleural space, is one of the most frequent postoperative complications after lung resection. To control air leak, there are two different products certified since years: TachoSil® and Neoveil®. This study is to investigate the difference of TachoSil® and Neoveil® in patients with PAL.

Conditions

Interventions

TypeNameDescription
OTHERTachoSil®topical absorbable fibrin sealant patch applied directly on the lung area with air fistula.
OTHERNeoveil®bioabsorbable soft-tissue reinforcement material applied on the normal shape of the lung at the end of the operation.

Timeline

Start date
2020-04-01
Primary completion
2021-07-01
Completion
2021-07-31
First posted
2019-08-22
Last updated
2023-05-15

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04065880. Inclusion in this directory is not an endorsement.

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation (NCT04065880) · Clinical Trials Directory